In a nutshell The authors examined whether rituximab was associated with the development of a second cancer after treatment for diffuse large B-cell lymphoma. The authors concluded that the number of patients with certain cancers has increased after rituximab was introduced. Some background Diffuse large B-cell lymphoma (DLBCL) is a very...
Read MoreOn going treatment(s)-Biological/Targeted therapy Posts on Medivizor
Pomalidomide is safe and effective for advanced multiple myeloma when combined with dexamethasone
In a nutshell This study examined the safety and effectiveness of pomalidomide (Pomalyst) for multiple myeloma patients who have received multiple prior therapies. Researchers reported improved treatment outcomes when pomalidomide was combined with the steroid drug dexamethasone (Decadron) compared to pomalidomide alone. Some background Standard...
Read More